BioCentury
ARTICLE | Finance

Venture tracks

Biotech investor, banker and analyst personnel changes

May 7, 2012 7:00 AM UTC

Scott Morenstein was promoted to managing director at Valence Life Sciences. He was principal at Caxton Advantage Venture Partners. Valence was formed in February by the founders of Caxton....